BMC accused of abandoning affordable healthcare as PPP shift pushes essential treatment beyond the reach of those who need it ...

Objectives Despite the clinical significance of neuropsychiatric systemic lupus erythematosus (NPSLE), which is a severe ...

Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in ...

The CELEBRATE trial testing the novel injectable glycoprotein IIb/IIIa inhibitor zalunfiban ( Disaggpro; CeleCor Therapeutics) before hospital admission in STEMI patients has met its primary safety ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...

Thrombocytopenia, or a low platelet count, can impair blood clotting, potentially leading to severe bleeding from wounds. Underlying health conditions like autoimmune diseases and cancers, as well as ...

In its guidance for schools, the Scottish Government is completely ignoring the evidence presented in the Cass Review. I ...

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types ...

DEL MAR, Calif., Sept. 23, 2025 /PRNewswire/ -- CeleCor Therapeutics' multinational Phase 3 clinical trial of its investigational heart-attack drug Disaggpro™ (zalunfiban) has shown positive primary ...

In its guidance for schools, the Scottish Government is completely ignoring the evidence presented in the. I can’t even find ...

While following any prescribed treatment is important, there are also vital steps you can take on your own to keep this blood disorder in check. Living with chronic immune thrombocytopenia (ITP), a ...